Fibrinolysis in Cholestatic Jaundice
作者： A. Jedrychowski , P. Hillenbrand , A. B. Ajdukiewicz , S. P. Parbhoo , S. Sherlock
关键词: Medicine 、 Antifibrinolytic agent 、 Gastroenterology 、 Endocrinology 、 Internal medicine 、 Common bile duct 、 Primary biliary cirrhosis 、 Urokinase 、 Fibrinolysis 、 Palliative care 、 Cholestasis 、 Bile duct
摘要: The fibrinolytic system was studied in primary biliary cirrhosis (16 patients) and large bile duct obstruction (10 patients, nine of whom had carcinoma). Plasma fibrinolysis (plasminogen activator activity) decreased fibrinogen increased both groups particularly those with obstruction. These changes were related to the degree cholestasis. Plasminogen activity inversely serum triglyceride levels patients cirrhosis. Urokinase inhibitors antiplasmins obstruction; fibrin/fibrinogen degradation products normal moderately None these indices Fibrinolytic returned almost after palliative surgery three who studied. plasma may be due altered lipid metabolism cholestatic jaundice. In undergoing for there an risk thrombosis.
sci-hub.se 参考文章(18)
P. J. NESTEL, The relationship between blood fibrinolytic activity, serum lipoproteins and serum cholesterol in atherosclerotic arterial disease. Australasian annals of medicine. ,vol. 9, pp. 234- 236 ,(1960) , 10.1111/IMJ.1960.9.3.234
Jan-Erik Niléhn, Inga Marie Nilsson, DEMONSTRATION OF FIBRINOLYTIC SPLIT PRODUCTS IN HUMAN SERUM BY AN IMMUNOLOGICAL METHOD IN SPONTANEOUS AND INDUCED FIBRINOLYTIC STATES. Scandinavian Journal of Haematology. ,vol. 1, pp. 313- 330 ,(2009) , 10.1111/J.1600-0609.1964.TB00029.X
P C Das, A G Allan, D G Woodfield, J D Cash, Fibrin degradation products in sera of normal subjects. BMJ. ,vol. 4, pp. 718- 720 ,(1967) , 10.1136/BMJ.4.5581.718
Tage Astrup, Sten Müllertz, The fibrin plate method for estimating fibrinolytic activity Archives of Biochemistry and Biophysics. ,vol. 40, pp. 346- 351 ,(1952) , 10.1016/0003-9861(52)90121-5
Isabel M. Riding, D. Ellis, Antiplasmin activity of β-lipoprotein Journal of Atherosclerosis Research. ,vol. 4, pp. 189- 193 ,(1964) , 10.1016/S0368-1319(64)80039-9
N. Edward, D. P.-G. Young, M. Macleod, Fibrinolytic activity in plasma and urine in chronic renal disease Journal of Clinical Pathology. ,vol. 17, pp. 365- 368 ,(1964) , 10.1136/JCP.17.3.365
P.O. Ganrot, Inhibition of plasmin activity by α2-macroglobulin Clinica Chimica Acta. ,vol. 16, pp. 328- 330 ,(1967) , 10.1016/0009-8981(67)90201-X
A Marzo, P Ghirardi, D Sardini, G Meroni, Simplified Measurement of Monoglycerides, Diglycerides, Triglycerides, and Free Fatty Acids in Biological Samples Clinical Chemistry. ,vol. 17, pp. 145- 147 ,(1971) , 10.1093/CLINCHEM/17.3.145
Inga Marie Nilsson, Hans Krook, Nils-Herman Sternby, Edvard Söderberg, Nils Söderström, Severe Thrombotic Disease in a Young Man with Bone Marrow and Skeletal Changes and with a High Content of an Inhibitor in the Fibrinolytic System Acta Medica Scandinavica. ,vol. 169, pp. 323- 337 ,(2009) , 10.1111/J.0954-6820.1961.TB07838.X
Gerald B. Phillips, THE LIPID COMPOSITION OF SERUM IN PATIENTS WITH LIVER DISEASE* Journal of Clinical Investigation. ,vol. 39, pp. 1639- 1650 ,(1960) , 10.1172/JCI104187